NASDAQ:SNWV Sanuwave Health (SNWV) Stock Price, News & Analysis $16.12 -0.35 (-2.09%) As of 02:07 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Sanuwave Health Stock (NASDAQ:SNWV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Sanuwave Health alerts:Sign Up Key Stats Today's Range$15.88▼$16.7150-Day Range$15.57▼$20.6152-Week Range$15.35▼$46.58Volume14,980 shsAverage Volume76,646 shsMarket Capitalization$138.68 millionP/E Ratio48.87Dividend YieldN/APrice Target$51.00Consensus RatingModerate Buy Company Overview Sanuwave Health, Inc. is a medical technology company specializing in the development and commercialization of non-invasive acoustic wave therapies designed to stimulate tissue regeneration and accelerate healing. The company’s proprietary Extracorporeal Pulse Activated Technology (EPAT) delivers focused acoustic pressure waves to injured or chronic wound sites, activating the body’s natural repair mechanisms. Sanuwave’s primary therapeutic areas include advanced wound care for diabetic and venous ulcers, as well as orthopedic and musculoskeletal conditions. The company’s lead product, the dermaPACE® system, holds clearance from the U.S. Food and Drug Administration for treatment of chronic diabetic foot ulcers. This portable, hand-held device provides a convenient alternative to conventional wound-care methods by delivering precision acoustic pulses directly to the affected tissue, thereby promoting neovascularization and reducing healing times. Sanuwave also supplies disposable treatment cartridges and related consumables to healthcare providers, and has established distribution agreements in North America and select overseas markets to broaden patient access. Headquartered in Alpharetta, Georgia, Sanuwave Health originated as Tissue Regeneration Systems, Inc. before adopting its current name to reflect an expanded focus on regenerative medicine technologies. Under the leadership of Chief Executive Officer Jeff Bean, the company continues to advance its clinical research programs, pursue regulatory clearances for additional indications, and explore strategic partnerships. Sanuwave’s ongoing mission is to deliver innovative, non-invasive therapeutic solutions that improve patient outcomes and reduce healthcare costs worldwide.AI Generated. May Contain Errors. Read More Sanuwave Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks45th Percentile Overall ScoreSNWV MarketRank™: Sanuwave Health scored higher than 45% of companies evaluated by MarketBeat, and ranked 688th out of 868 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingModerate Buy Consensus RatingSanuwave Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, 1 buy rating, 1 hold rating, and 1 sell rating.Upside PotentialSanuwave Health has a consensus price target of $51.00, representing about 216.3% upside from its current price of $16.13.Amount of Analyst CoverageSanuwave Health has only been the subject of 3 research reports in the past 90 days.Read more about Sanuwave Health's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Sanuwave Health is 48.87, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.31.Price to Earnings Ratio vs. SectorThe P/E ratio of Sanuwave Health is 48.87, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.14.Price to Book Value per Share RatioSanuwave Health has a P/B Ratio of 84.87. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Sanuwave Health's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted11.01% of the float of Sanuwave Health has been sold short.Short Interest Ratio / Days to CoverSanuwave Health has a short interest ratio ("days to cover") of 6.04.Change versus previous monthShort interest in Sanuwave Health has recently increased by 5.47%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSanuwave Health does not currently pay a dividend.Dividend GrowthSanuwave Health does not have a long track record of dividend growth. News and Social Media3.1 / 5News Sentiment0.94 News SentimentSanuwave Health has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.84 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Sanuwave Health this week, compared to 2 articles on an average week.MarketBeat Follows1 people have added Sanuwave Health to their MarketBeat watchlist in the last 30 days. Company Ownership1.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Sanuwave Health insiders have not sold or bought any company stock.Percentage Held by Insiders14.40% of the stock of Sanuwave Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions42.53% of the stock of Sanuwave Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Sanuwave Health's insider trading history. Receive SNWV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sanuwave Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SNWV Stock News HeadlinesSANUWAVE Health Inc (SNWV) Q1 2026 Earnings Call Highlights: Record Revenue Amid Market ChallengesMay 13, 2026 | finance.yahoo.comSANUWAVE Health Balances Growth, Margin Pressure in Q1May 13, 2026 | tipranks.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.June 1 at 1:00 AM | Profits Run (Ad)Sanuwave (SNWV) Q1 2026 Earnings TranscriptMay 13, 2026 | fool.comSANUWAVE Health Inc Reports Q1 2026 Results: Full Earnings Call TranscriptMay 13, 2026 | uk.finance.yahoo.comSANUWAVE Health, Inc. (SNWV) Q1 2026 Earnings Call TranscriptMay 13, 2026 | seekingalpha.comSanuwave Announces Revenues and Financial Results for Q1 FY2026May 12, 2026 | globenewswire.comHow The SANUWAVE Health (SNWV) Investment Story Is Shifting Around The US$43.50 TargetMay 12, 2026 | finance.yahoo.comSee More Headlines SNWV Stock Analysis - Frequently Asked Questions How have SNWV shares performed this year? Sanuwave Health's stock was trading at $29.84 at the beginning of the year. Since then, SNWV stock has decreased by 46.0% and is now trading at $16.1250. How were Sanuwave Health's earnings last quarter? Sanuwave Health Inc. (NASDAQ:SNWV) issued its earnings results on Tuesday, May, 12th. The company reported ($0.17) EPS for the quarter, missing analysts' consensus estimates of ($0.14) by $0.03. The company had revenue of $9.62 million for the quarter, compared to analysts' expectations of $9.60 million. Sanuwave Health had a negative trailing twelve-month return on equity of 450.56% and a net margin of 35.96%. Read the conference call transcript. When did Sanuwave Health's stock split? Shares of Sanuwave Health reverse split on the morning of Friday, October 18th 2024.The 1-375 reverse split was announced on Wednesday, October 16th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 17th 2024. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split. Who are Sanuwave Health's major shareholders? Sanuwave Health's top institutional investors include Stonebridge Wealth Management LLC (0.43%) and Bank of America Corp DE (0.30%). Insiders that own company stock include Peter Stegagno and Iulian Cioanta. View institutional ownership trends. How do I buy shares of Sanuwave Health? Shares of SNWV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Sanuwave Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Sanuwave Health investors own include Co-Diagnostics (CODX), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Kopin (KOPN) and VBI Vaccines (VBIV). Company Calendar Last Earnings5/12/2026Today6/01/2026AGM 20266/11/2026Next Earnings (Estimated)8/14/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:SNWV Previous SymbolNASDAQ:SNWV CIK1417663 WebN/A Phone(770) 419-7525Fax770-419-8634Employees40Year Founded2005Price Target and Rating Average Price Target for Sanuwave Health$51.00 High Price Target$55.00 Low Price Target$47.00 Potential Upside/Downside+214.5%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)$0.33 Trailing P/E Ratio48.97 Forward P/E RatioN/A P/E GrowthN/ANet Income$11.81 million Net Margins35.96% Pretax Margin37.15% Return on Equity-450.56% Return on Assets44.87% Debt Debt-to-Equity Ratio8.15 Current Ratio1.31 Quick Ratio0.99 Sales & Book Value Annual Sales$44.05 million Price / Sales3.17 Cash Flow$1.67 per share Price / Cash Flow9.70 Book Value$0.19 per share Price / Book85.34Miscellaneous Outstanding Shares8,600,000Free Float7,361,000Market Cap$139.45 million OptionableN/A Beta1.34 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free Report This page (NASDAQ:SNWV) was last updated on 6/1/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredJune 12: $100 Turns Into $100,000?The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...Brownstone Research | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanuwave Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanuwave Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
